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 Introduction 
 Th e purpose of evidence-based medicine is to apply the best 
scientifi c evidence to clinical decision-making. In order to guide 
doctors and health professionals, the Royal Colleges publish 
guidelines and recommendations for good clinical practice within 
their respective specialties. 
 However, guidelines have limitations. Critics (Wright 2007) say 
that they are unsuited to address fl exibility and choice expected 
by patients. Browman (2010) argues that it is tempting to develop 
rigid protocols but patient treatment should be individualised. 
However, in the area of acute obstetrics and gynaecology, where 
management of life-threatening conditions is unsuitable for 
randomised controlled trials, guidelines are heavily relied upon, 
to ensure consistent quality of care. Many are based on recom-
mendations which have little or no scientifi c background and 
rely more on clinical or expert opinion, which is particularly 
susceptible to bias (Detsky 1924). Wright (2007) argues that while 
the evidence-based medicine movement was intended to add 
evidential basis to guideline recommendations, it only resulted in 
a moderate improvement. Wright is also sceptical of the system 
of grading recommendations according to evidence (Grade A, 
Grade B, etc.), as some readers of guidelines may not consult the 
type of evidence underlying each grade. Th is has led analysts of 
evidence-based medicine to claim that this is a misnomer and it is 
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 Evidence-based medicine aims to translate scientifi c research 
into good medical practice. The Royal College of Obstetricians 
and Gynaecologists publishes recommendations and guidelines 
to guide clinicians in decision-making. In this study, the evidence 
base underlying the  ‘ Green-top Guidelines ’ has been analysed 
in order to establish the quality of research underlying recom-
mendations. During this descriptive study of 1,682 individual 
recommendations, the authors found that only 9 – 12% of the 
guidelines were based on the best quality (Grade A) evidence. 
The authors believe that this type of analysis serves to provide 
greater clarity for clinicians and patients using guidelines and 
recommendations in the fi eld of obstetrics and gynaecology to 
make collaborative clinical decisions. 
 Keywords:  Evidence-based medicine ,  guidelines ,  gynaecology , 
 obstetrics ,  RCOG 
actually better referred to as  ‘ eminence-based medicine ’ (Charles 
et  al. 2011). 
 Th ere have been no previous analyses of the overall evidence 
underlying the Royal College of Obstetricians and Gynaecologists 
(RCOG) guidelines. However, a study by Wright in 2011 found 
that only one-third of the recommendations by the American 
College of Obstetricians and Gynecologists were based on good 
scientifi c evidence (Wright et  al. 2011). In similar studies, this 
was the case in 14% of the recommendations by the Infectious 
Diseases Society of America (Lee and Vielemeyer 2011), and 45% 
of cardiovascular risk recommendations from guidelines across 
the USA, Canada and Europe (McAlister et  al. 2007). 
 Th e objective of this study was to analyse the evidence used in 
guidelines published by the RCOG and to identify areas where 
evidence is high-quality, adequate or lacking. It is important to 
be aware of the standard of evidence which underpins the advice 
which doctors access for the diagnosis and management of their 
patients. 
 Materials and methods 
 Th e Royal College of Obstetricians and Gynaecologists produces 
a large number of guidelines for the management and diagnosis 
of a wide variety of diseases and conditions. Th e College produces 
diff erent categories of advice:  ‘ Consent Advice ’,  ‘ Good Practice ’, 
 ‘ Joint Guidelines ’,  ‘ National Evidence Based Guidelines ’ and 
 ‘ Project Reports ’, among others. For the purpose of this analysis, 
we used the  ‘ Green-top Guidelines ’. Each Green-top Guideline 
addresses a specifi c topic, giving a brief introduction to the sub-
ject in question and detailing how the supporting evidence was 
obtained. For the guidelines included, see Table I. Th e guidelines 
themselves include a series of recommendations, each graded by 
the overall quality of supporting evidence, the details of which 
are included in Table II. In addition, the studies and trials cited 
in support of the recommendations made were further classi-
fi ed using a numerical system, which has not been included for 
simplifi cation. Th e method of grading of recommendations and 
classifi cation of evidence was changed in December 2007. For this 
reason, guidelines created before that date and guidelines created 
aft er that date were analysed separately to avoid the introduction 
of any bias or subjectivity into classifi cation. 
 All 52  ‘ Green-top Guidelines ’ were obtained from the Royal 
College of Obstetricians and Gynaecologists ’ website on 1 April 
2012. One guideline (Green-top 31,  ‘ Small-for-Gestational-Age 
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 Table I. Th e Green-top Guidelines analysed. 
Guideline number Date published
Amniocentesis and Chorionic Villus Sampling 8 Jun 2010
Antenatal Corticosteroids to Reduce Neonatal Morbidity 7 Oct 2010
Antepartum Haemorrhage 68 Dec 2011
Birth Aft er Previous Caesarean Birth 45 Feb 2007
Blood Transfusions in Obstetrics 47 Dec 2007
Breast Cancer and Pregnancy 12 Apr 2011
Breech Presentation, Management 20b Dec 2006
Cervical Cerclage 60 May 2011
Chickenpox in Pregnancy 1 Sep 2007
Chronic Pelvic Pain, Initial Management 41 Apr 2005
Early Pregnancy Loss, Management 25 Oct 2006
Endometriosis, Investigation and Management 24 Oct 2006
External Cephalic Version (ECV) and Reducing the Incidence of Breech Presentation 20a Dec 2006
Female Genital Mutilation Management 53 May 2009
Genital Herpes in Pregnancy, Management 30 Sep 2007
Gestational Trophoblastic Disease 38 Feb 2010
Group B Streptococcal Disease, Early Onset 36 Nov 2003
HIV in Pregnancy, Management 39 Jun 2010
Hormone Replacement Th erapy and Venous Th romboembolism 19 May 2011
Hysteroscopy, Best Practice in Outpatient 59 Apr 2011
Laparoscopic Injuries 49 May 2008
Late Intrauterine Fetal Death and Stillbirth 55 Nov 2010
Malaria in Pregnancy Diagnosis and Treatment 54b Apr 2010
Malaria in Pregnancy Prevention 54a Apr 2010
Maternal Collapse in Pregnancy and the Puerperium 56 Feb 2011
Monochorionic Twin Pregnancy, Management 51 Dec 2008
Obstetric Cholestasis 43 Apr 2011
Operative Vaginal Delivery 26 Feb 2011
Ovarian Cysts in Postmenopausal Women 34 Oct 2003
Ovarian Hyperstimulation Syndrome, Management 5 Sep 2006
Ovarian Masses in Premenopausal Women: Management of Suspected 62 Dec 2011
Pelvic Inﬂ ammatory Disease 32 Nov 2008
Placenta Praevia and Placenta Praevia Accreta: Diagnosis and Management 27 Jan 2011
Polycystic Ovary Syndrome, Long-Term Consequences 33 Dec 2007
Postpartum Haemorrhage, Prevention and Management 52 May 2009
Premenstrual Syndrome, Management 48 Dec 2007
Preterm Labour, Tocolytic Drugs 1b Feb 2011
Preterm Prelabour Rupture of Membranes 44 Nov 2006
Recurrent Miscarriage, Investigation and Treatment of Couples 17 Apr 2011
Reduced Fetal Movements 57 Feb 2011
Rh Prophylaxis, Anti-D Immunoglobulin 22 Mar 2011
Shoulder dystocia 42 Mar 2012
Sickle Cell Disease in Pregnancy, Management 61 Aug 2011
Th ird- and Fourth-degree Perineal Tears, Management 29 Mar 2007
Th romboembolic Disease in Pregnancy and the Puerperium: Acute Management 37b Feb 2007
Th rombosis and Embolism during Pregnancy and the Puerperium, Reducing the Risk 37a Nov 2009
Tubal Pregnancy, Management 21 May 2004
Umbilical Cord Prolapse 50 Apr 2008
Vaginal Vault Prolapse 46 Oct 2007
Venous Th romboembolism and Hormonal Contraception 40 Sep 2010
Venous Th romboembolism and Hormone Replacement Th erapy 19 May 2011
Vulval Skin Disorders, Management 58 Feb 2011
Fetus, Investigation and Management ’, published on 1 November 
2002) was not included in the analysis, as its evidence levels were 
classifi ed using a diff erent system from the others. Two guidelines 
have been archived by the RCOG (Green-tops 10A and 35), with 
advice to refer to the appropriate National Institute of Clinical 
Excellence (NICE) guidelines for assistance, and therefore could 
not be obtained or included in analysis. 
 RCOG Green-top guidelines published before December 
2007 are classifi ed according to one of four levels of evidence:  A 
(literature of overall good quality and evidence);  B (well controlled 
clinical studies);  C (evidence from expert committee reports 
or opinions) and  √ (recommended best practice based on the 
clinical experience of the guideline development group). Th ose 
issued from December 2007 were classifi ed using a fi ve-tiered 
system:  A (meta-analysis, systematic review or a good quality 
randomised controlled trial);  B (high quality systematic reviews 
of case – control or cohort studies);  C (high quality case – control 
or cohort studies with a low risk of confounding);  D (non-
analytical studies, such as case reports/expert opinion) and  √ 
(recommended best practice based on the clinical experience of 
the guideline group). 
 We gathered the grades of each recommendation within 
each guideline, and then stratifi ed each guideline into those 
primarily focussed on obstetrics and those primarily focussed 
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 Table II. Th e classiﬁ cation scheme for the recommendations by the Royal College of Obstetricians and Gynaecologists. 
Classiﬁ cation scheme for recommendations by the Royal College of Obstetricians and Gynaecologists
Pre-December 2007
 A At least one randomised controlled trial as part of a body of literature of overall good quality and consistency addressing 
the speciﬁ c recommendation.
 B Requires the availability of well controlled clinical studies but no randomised clinical trials on the topic of 
recommendations.
 C Requires evidence obtained from expert committee reports or opinions and/or clinical experiences or respected authorities. 
Indicates an absence of directly applicable clinical studies of good quality.
 D Recommended best practice based on the clinical experience of the guideline development group.
Post-December 2007
 A At least one meta-analysis, systematic review or randomised controlled trial rated as 1   directly applicable to the target 
population and demonstrating overall consistency of results.
 A systematic review of randomised controlled trials or a body of evidence consisting principally of studies rated as 
1    directly applicable to the target population and demonstrating overall consistency of results.
 B A body of evidence including studies rated as 2   directly applicable to the target population, and demonstrating overall 
consistency of results.
 Extrapolated evidence from studies rated as 1   or 1  .
 C A body of evidence including studies rated as 2    directly applicable to the target population and demonstrating overall 
consistency of results.
 Extrapolated evidence from studies rated as 2   .
 D Evidence level 3 or 4.
 Extrapolated evidence from studies rated as 2  .
 E Recommended best practice based on the clinical experience of the guideline development group.
on gynaecology. We then sub-divided the latter into the follow-
ing: General Gynaecology, Oncology, Fertility and Endoscopy. 
In addition to this, we sorted the guidelines based on whether 
they referred to Evaluation, Diagnosis and Treatment, or Mode 
of Delivery (Table III). Th is was carried out independently by 
three reviewers; categorisations were then discussed and any 
discrepancies were resolved by consensus (majority opinion of 
all the reviewers). Descriptive statistics were then used to report 
the fi ndings of this analysis. Th e Research Management and 
Governance Department at the Whittington Hospital, UK, agreed 
that the project did not require NHS ethics approval. 
 Table III. Th e classiﬁ cation scheme for the stratiﬁ cation of guidelines into 
topics. 
Classiﬁ cation scheme for the 
stratiﬁ cation of guidelines into topics
Guideline specialty 
grouping
Obstetrics
Gynaecology General Gynaecology
Oncology
Fertility
Endoscopy
Guideline 
classiﬁ cation 
scheme
Diagnosis and 
treatment
Recommendations for the diagnostic 
evaluation in patients without a 
known abnormal condition, and for 
the speciﬁ c interventions for the 
diagnosed condition.
Evaluation Recommendation for evaluation, 
monitoring, and follow-up of 
patients with a known abnormal 
condition.
Mode of 
delivery
Recommendations speciﬁ cally tailored 
to directing for a particular mode of 
delivery (obstetrics guidelines only).
 Results 
 A total of 52 guidelines that off ered 1,682 individual recommen-
dations were studied (Table I); 32 of the guidelines were obstet-
ric (61.5%) and 20 were gynaecological (38.5%). Within these 
guidelines, 1,160 (69%) of the individual recommendations were 
obstetric and 522 (31%) were gynaecological. Of the recommen-
dations published before December 2007, 52 (12%) referenced 
level A evidence; 94 (22%) level B evidence; 126 (29%) level C 
evidence; and 163 (37%) were based on recommended best prac-
tice (Figure 1a). Regarding guidelines published from December 
2007 onwards, 114 (9%) were based on level A evidence; 145 
(12%) level B; 210 (17%) level C; 276 (22%) level D and 502 (40%) 
were recommended best practice (Figure 1b). Th is suggests that, 
contrary to the aims of evidence-based medicine, guidelines pub-
lished more recently are actually more likely to be based on clini-
cal experience alone. However, since the new classifi cation system 
places more stringent measures on evidence that can qualify as 
level A, the two sub-sets cannot be directly compared. 
 Within the two classifi cation systems (that used prior to 
December 2007 and that used aft er), the distribution of quality 
of evidence was divided into that supporting obstetric guidelines 
and that supporting gynaecological guidelines. Among the obstet-
ric recommendations published under the old system, 22 (8%) 
provided level A evidence; 48 (18%) level B; 89 (33%) level C and 
111 (41%) were recommended best practice (Figure 2a). Of those 
published aft er December 2007, using the new fi ve-tiered system, 
69 (8%) provided level A evidence; 93 (10%) level B; 147 (16%) 
level C; 229 (26%) level D and 352 (40%) were recommended best 
practice (Figure 2b). Th is suggests there has been no signifi cant 
change in the quality of sources of evidence used by the RCOG 
to write obstetric guidelines over the past few years, and that 
the greater reliance of more recently published guidelines by the 
RCOG on clinical experience alone is due to the newer gynaeco-
logical rather than obstetric guidelines. 
 Among the gynaecological recommendations published before 
December 2007, 30 (18%) were based on level A evidence; 46 
(28%) level B; 37 (22%) level C and 52 (32%) were recommended 
best practice (Figure 3a). In those published post-December 2007, 
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 Figure 1. Classiﬁ cation of evidence levels underlying RCOG guidelines 
published (a) before and (b) aft er December 2007. 
 Figure 2. Classiﬁ cation of evidence underlying Obstetrics guidelines 
published (a) before and (b) aft er December 2007. 
 Figure 3. Classiﬁ cation of evidence underlying Gynaecology guidelines 
published (a) before and (b) aft er December 2007. 
 Figure 4. Distribution of quality of evidence underlying obstetric recom-
mendations stratiﬁ ed by the type of guideline, published (a) before and (b) 
aft er December 2007. 
45 (13%) provided level A evidence; 52 (14%) level B; 63 (18%) 
level C; 47 (13%) level D and 150 (42%) were recommended best 
practice (Figure 3b). Th is demonstrates that across all guidelines 
(regardless of publication date), those concerned with gynaecol-
ogy had a higher quality of underlying evidence than obstetric 
guidelines, with greater numbers based on the fi ndings of meta-
analyses and well-conducted randomised controlled trials. 
 Th e recommendations were then further stratifi ed by our clas-
sifi cation scheme. Within obstetrics, 68.8% of recommendations 
addressed diagnosis and treatment; 12.5% evaluation and 18.8% 
mode of delivery. Within gynaecology, 85% of recommendations 
addressed diagnosis and treatment and 15% evaluation. Once 
again, those published under each of the two classifi cation systems 
had to be evaluated separately. Of the obstetric guidelines published 
under the old system, 5.6% of guidelines concerning evaluation 
were based on level A treatment, compared with 6.4% of diagnosis 
and treatment, and 12.5% of mode of delivery recommendations 
(Figure 4a). Of the newer obstetric guidelines, 6.4% of evaluation, 
8.1% of diagnosis and treatment and 7.4% of mode of delivery 
recommendations were based on level A evidence (Figure 4b). 
 Of the older gynaecological guidelines, 14.3% of evaluative and 
18.8% of diagnostic and treatment recommendations were based 
on level A evidence (Figure 5a), compared with 0% of evaluative 
and 15.1% of diagnostic and treatment recommendations pub-
lished under the new classifi cation system (Figure 5b). 
 Th e 20 gynaecology guidelines were further categorised by 
subspecialty; the majority (70%) addressed general gynaecology 
issues; 20% were concerned with fertility; 5% with oncology and 
5% with endoscopy. Th e results showed that 10.8% of fertility 
guidelines published under the old system and 20.8% of those 
published more recently, were based on level A evidence, com-
pared with 24.2% and 7.3% of general gynaecology guidelines 
published before and aft er December 2007, respectively. Th ere 
was only one guideline related to gynaecological oncology, for 
which none of the evidence was level A. Conversely, the only 
endoscopy guideline was based on evidence, of which 42.3% was 
level A (Figure 6). 
 Overall, the results suggest that the majority of supportive evi-
dence behind the RCOG guidelines is based on clinical expertise 
or studies defi ned as low quality, and that this does not appear to 
be changing with new guidelines. Gynaecological guidelines seem 
to generally have a higher quality evidence base than obstetric 
recommendations. 
 Discussion 
 Th e fi ndings of this guideline analysis suggest that on average 
across the categories, fewer than 20% of recommendations by the 
RCOG were based on high quality evidence, with a large propor-
tion based on  ‘ recommended best practice ’ and expert opinion. 
We go on to question why this is so and what this means in an era 
of evidence-based practice. 
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710 K. Prusova et al. 
 Figure 6. Quality of evidence underlying gynaecological subspecialty guide-
lines, published (a) before and (b) aft er December 2007. 
 Figure 5. Distribution of quality of evidence underlying gynaecology recom-
mendations stratiﬁ ed by the type of guideline, published (a) before and (b) 
aft er December 2007. 
 Th e  ‘ Green-top Guidelines ’ reviewed in this study are written 
and developed by the RCOG to provide systematic recommenda-
tions in the hope of assisting clinicians and patients in clinical 
decision-making. Guideline topics are selected through a process 
coordinated by the Guidelines and Audit Committee, made up 
of clinicians, with input from the RCOG Consumers ’ Forum. 
Guidelines are developed by collating evidence and making value 
judgements by consensus. Th ey must then meet the Appraisal 
of Guidelines for Research and Evaluation in Europe (AGREE) 
criteria and are subsequently peer reviewed in a formal, open 
process. Th e system used by the RCOG to grade the evidence 
quality is based on the scoring system developed by the  ‘ GRADE 
Working Group ’ (Balsham et  al. 2011). Th is is intended to intro-
duce further rigour into the classifi cation of evidence quality 
underlying guidelines. However, there is also concern that such 
a simplistic representation of evidence (stating quality as A, B or 
C) might not communicate an accurate enough interpretation of 
quality (Charles et  al. 2011). Recommendations are not intended 
to be used exclusively to decide upon a course of management 
or treatment; instead the clinician ’ s judgement should also give 
equal consideration to individual patient needs and the variation 
of recourses between institutions (RCOG 2012). 
 Th e recent Institute of Medicine report in the USA on the 
development of guidelines and their worth in modern practice 
highlights the fact that guidelines can be fl awed in their forma-
tion; such fl aws may be due to a lack of transparency in how they 
are created and rated, and an absence of rigorous external review. 
Th ey suggest that authors of guideline recommendations should 
provide a summary of the quality of the evidence they have used 
(Institute of Medicine, no date). 
 Research in obstetrics and gynaecology, as in other fi elds (Lee 
and Vielemeyer 2011; McAlister et  al. 2007) is clearly lacking in 
randomised controlled trials. Th is can be put down to several fac-
tors. Th e acute nature of the specialty means there are ethical and 
practical diffi  culties that make trial design and implementation 
impossible (Lee and Vielemeyer 2011). Some have postulated that 
practice based on such  ‘ real-life ’ observational evidence might 
be of more value in obstetrics than randomised control trials 
(Vintzileos 2009), however, this evidence would be prone to error 
and bias. In addition, only a minority of obstetricians conduct 
a literature search when presented with a clinical dilemma, and 
personal experience and views of experts still have a far-reaching 
infl uence over obstetric practice (Olatunbosun et  al. 1998). 
 It is also important to acknowledge the uniqueness of obstetric 
practice in relation to its partner, midwifery. Th e ancient tradition 
and long history of midwifery has its own body of expert opinion, 
based on historical and research experience, and Th e Royal Col-
lege of Midwives has its own set of online guidelines, which does 
not use the GRADE system. 
 Within the subspecialties of obstetrics and gynaecology, there 
is a diff erence in quality of supportive evidence; endoscopy, a 
relatively new intervention in this fi eld, would require evidence 
to prove its value and would have the fi nancial backing needed to 
provide this  – the sole endoscopy guideline was based on 42.3% 
level A evidence. However, some Grade C recommendations 
for established practice can be very useful in a  ‘ common sense ’ 
way. For example, that low risk postpartum women do not need 
thromboprophylaxis (RCOG 2009). Even fundamental corner-
stones of clinical practice, such as partograms, are not based 
on strong evidence. A review of the use of partograms on birth 
outcomes conducted by the Cochrane Collaboration concluded 
that they could not recommend the routine use of the partogram 
as part of standard labour management (Lavender et  al. 2008). 
Zhang (2002) also found that the average labour of nulliparous 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 C
oll
eg
e L
on
do
n]
 at
 07
:49
 28
 Se
pte
mb
er 
20
15
 
Royal College of Obstetricians and Gynaecologists guidelines 711
women varies markedly from the Friedman curve during the fi rst 
stage of labour, and as such, it is possible that interventions for 
slow progression may come too early due to overly strict guide-
lines (Zhang et  al. 2002). Yet the partogram remains an important 
foundation of intrapartum care in the UK. Even when there is 
supposedly good quality evidence underpinning guidelines, this is 
sometimes fl awed  – a case in point is the issue of caesarean deliv-
ery of breech presentations. Th e publication of the Term Breech 
Trial (Hannah 2000), a multicentre randomised trial, implied that 
it was safer to perform a caesarean section at birth for all breech 
infants, and as such, it was incorporated into guidelines in the 
USA, UK and Canada. However, a  post hoc inquiry into this trial ’ s 
methodology has revealed inconsistencies and errors in data col-
lection and analysis, which make the study ’ s fi ndings unreliable 
(Kotaska 2011). 
 We accept that there are several limitations to this study. Th e 
categorisation system developed was designed to assist us in pro-
viding meaningful conclusions. However, the introduction of such 
rigid parameters may be detrimental to the accuracy of the analy-
sis. Naturally this system is dependent on the reviewer, and other 
researchers may diff er in their approach to classifi cation. We have 
modelled our analysis on the study published by Wright et  al. (2011) 
to facilitate meaningful comparison between the two papers. 
 Th is analysis has revealed that the majority of guideline 
recommendations were not underpinned by high quality 
evidence. Th e same sort of discourse is occurring in the basic 
sciences, as in the  New Scientist article:  ‘ Is medical science built 
on shaky foundations? ’, which raises the point that more than half 
of biomedical fi ndings cannot be reproduced (Iorns, 2012). One 
could ponder the impact of these conclusions that, in both the 
UK and USA, the majority of practice guidelines are not founded 
on high quality evidence, and this is refl ected in clinical practice, 
in science and medicine across the board. We should not dismiss 
the limitations of the RCOG or ACOG recommendations, but 
acknowledge them in order to neutralise any assumptions made 
by clinician or patient that recommendations are based on high 
quality evidence. 
 All medical colleges could off er this form of descriptive analytic 
summary of the quality of evidence their guidelines are based on. 
Th is would provide greater clarity for clinicians as to the core sci-
entifi c foundations of their clinical practice, as well as serving to 
aid transparency of speciality knowledge in the clinician – patient 
partnership of decision-making. 
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